| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Atrophy | 28 | 2022 | 84 | 6.470 |
Why?
|
| Renal Insufficiency, Chronic | 38 | 2023 | 776 | 5.070 |
Why?
|
| Muscle, Skeletal | 42 | 2021 | 1054 | 4.970 |
Why?
|
| Muscle Proteins | 22 | 2022 | 424 | 3.160 |
Why?
|
| Ubiquitin | 20 | 2015 | 148 | 3.040 |
Why?
|
| Proteasome Endopeptidase Complex | 20 | 2017 | 271 | 2.840 |
Why?
|
| Kidney Failure, Chronic | 26 | 2018 | 911 | 2.530 |
Why?
|
| Kidney Diseases | 13 | 2013 | 504 | 2.450 |
Why?
|
| Cachexia | 11 | 2022 | 52 | 2.440 |
Why?
|
| Water Purification | 4 | 2024 | 18 | 2.410 |
Why?
|
| Diet, Protein-Restricted | 10 | 2016 | 82 | 2.360 |
Why?
|
| Myostatin | 8 | 2016 | 21 | 2.020 |
Why?
|
| STAT3 Transcription Factor | 4 | 2020 | 230 | 1.920 |
Why?
|
| Keto Acids | 6 | 2016 | 56 | 1.650 |
Why?
|
| Renal Insufficiency | 6 | 2023 | 249 | 1.650 |
Why?
|
| Water Pollutants, Chemical | 5 | 2024 | 38 | 1.600 |
Why?
|
| Renal Dialysis | 22 | 2020 | 875 | 1.540 |
Why?
|
| Hydrogen Peroxide | 4 | 2024 | 129 | 1.470 |
Why?
|
| Kidney | 12 | 2023 | 1410 | 1.370 |
Why?
|
| Signal Transduction | 33 | 2020 | 4893 | 1.280 |
Why?
|
| Caspase 3 | 13 | 2015 | 139 | 1.260 |
Why?
|
| Insulin Resistance | 7 | 2020 | 685 | 1.230 |
Why?
|
| Proteolysis | 3 | 2020 | 193 | 1.150 |
Why?
|
| Disinfection | 3 | 2024 | 29 | 1.050 |
Why?
|
| Parathyroid Hormone | 2 | 2017 | 78 | 1.040 |
Why?
|
| Body Composition | 3 | 2020 | 564 | 1.030 |
Why?
|
| Wasting Syndrome | 7 | 2016 | 25 | 0.970 |
Why?
|
| Dietary Proteins | 4 | 2013 | 255 | 0.950 |
Why?
|
| Oxidation-Reduction | 3 | 2024 | 465 | 0.950 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2020 | 508 | 0.940 |
Why?
|
| Protein Biosynthesis | 3 | 2020 | 676 | 0.920 |
Why?
|
| Acidosis | 7 | 2016 | 102 | 0.900 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2020 | 107 | 0.900 |
Why?
|
| Halogenation | 2 | 2014 | 6 | 0.870 |
Why?
|
| Animals | 67 | 2023 | 36364 | 0.860 |
Why?
|
| Acetamides | 2 | 2014 | 50 | 0.830 |
Why?
|
| Alkanes | 1 | 2022 | 4 | 0.820 |
Why?
|
| Charcoal | 1 | 2022 | 7 | 0.820 |
Why?
|
| Muscular Diseases | 4 | 2017 | 117 | 0.810 |
Why?
|
| Mice, Knockout | 22 | 2022 | 3968 | 0.790 |
Why?
|
| Insulin | 10 | 2022 | 1246 | 0.730 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2014 | 352 | 0.730 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 123 | 0.720 |
Why?
|
| Proteins | 8 | 2013 | 1087 | 0.720 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2010 | 351 | 0.710 |
Why?
|
| Mice | 41 | 2023 | 18876 | 0.710 |
Why?
|
| Interleukin-6 | 7 | 2020 | 452 | 0.690 |
Why?
|
| Naphthols | 1 | 2020 | 8 | 0.680 |
Why?
|
| Angiotensin II | 5 | 2020 | 168 | 0.680 |
Why?
|
| Malnutrition | 5 | 2012 | 218 | 0.680 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 30 | 0.670 |
Why?
|
| Adipose Tissue, White | 2 | 2019 | 90 | 0.670 |
Why?
|
| Histone Demethylases | 1 | 2020 | 44 | 0.670 |
Why?
|
| F-Box Proteins | 1 | 2020 | 37 | 0.660 |
Why?
|
| Dioxygenases | 1 | 2020 | 65 | 0.660 |
Why?
|
| Receptor, Insulin | 2 | 2013 | 70 | 0.660 |
Why?
|
| Nephrology | 5 | 2021 | 152 | 0.650 |
Why?
|
| Fibrosis | 12 | 2022 | 465 | 0.650 |
Why?
|
| Weight Gain | 2 | 2020 | 414 | 0.640 |
Why?
|
| Protein-Energy Malnutrition | 5 | 2013 | 76 | 0.630 |
Why?
|
| Drinking Water | 2 | 2024 | 17 | 0.630 |
Why?
|
| Arteriovenous Shunt, Surgical | 5 | 2020 | 94 | 0.620 |
Why?
|
| Regeneration | 3 | 2010 | 231 | 0.610 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2019 | 151 | 0.580 |
Why?
|
| Sulfonamides | 1 | 2020 | 285 | 0.580 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2015 | 262 | 0.560 |
Why?
|
| Insulin Receptor Substrate Proteins | 6 | 2020 | 80 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 20 | 2020 | 4799 | 0.560 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2017 | 9 | 0.550 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 608 | 0.550 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 2 | 2015 | 9 | 0.550 |
Why?
|
| Humans | 93 | 2023 | 133809 | 0.540 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 78 | 0.530 |
Why?
|
| Peptide Hydrolases | 4 | 2010 | 151 | 0.530 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2016 | 13 | 0.520 |
Why?
|
| Kidney Transplantation | 2 | 2020 | 686 | 0.520 |
Why?
|
| Caspases | 7 | 2010 | 167 | 0.510 |
Why?
|
| Disinfectants | 3 | 2024 | 28 | 0.510 |
Why?
|
| Neointima | 5 | 2020 | 47 | 0.510 |
Why?
|
| Phosphorylation | 8 | 2020 | 1702 | 0.500 |
Why?
|
| Chlorine | 3 | 2022 | 17 | 0.490 |
Why?
|
| Cell Line | 9 | 2020 | 2837 | 0.490 |
Why?
|
| Ultraviolet Rays | 3 | 2024 | 215 | 0.490 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2015 | 5 | 0.480 |
Why?
|
| Muscles | 3 | 2023 | 307 | 0.470 |
Why?
|
| Uremia | 2 | 2005 | 36 | 0.470 |
Why?
|
| Chronic Disease | 9 | 2016 | 1255 | 0.460 |
Why?
|
| Disease Models, Animal | 16 | 2020 | 4769 | 0.450 |
Why?
|
| Nitrobenzenes | 1 | 2014 | 18 | 0.450 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2020 | 243 | 0.450 |
Why?
|
| Nitrosamines | 1 | 2014 | 21 | 0.450 |
Why?
|
| Gases | 1 | 2014 | 20 | 0.450 |
Why?
|
| Aniline Compounds | 1 | 2014 | 21 | 0.450 |
Why?
|
| Glucocorticoids | 5 | 2009 | 408 | 0.440 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 536 | 0.430 |
Why?
|
| Biochemistry | 1 | 2013 | 11 | 0.430 |
Why?
|
| Renal Replacement Therapy | 2 | 2014 | 155 | 0.430 |
Why?
|
| Endothelial Cells | 5 | 2020 | 543 | 0.410 |
Why?
|
| Homeostasis | 3 | 2017 | 751 | 0.410 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2020 | 173 | 0.410 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 289 | 0.410 |
Why?
|
| Rats | 14 | 2020 | 3878 | 0.410 |
Why?
|
| Nutrition Disorders | 3 | 2003 | 32 | 0.400 |
Why?
|
| Satellite Cells, Skeletal Muscle | 2 | 2010 | 37 | 0.400 |
Why?
|
| Acetonitriles | 1 | 2012 | 3 | 0.400 |
Why?
|
| Myoblasts, Skeletal | 2 | 2014 | 12 | 0.400 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 5 | 2020 | 20 | 0.400 |
Why?
|
| Diet, Reducing | 1 | 2013 | 93 | 0.400 |
Why?
|
| MicroRNAs | 3 | 2021 | 951 | 0.400 |
Why?
|
| Ubiquitin-Protein Ligases | 8 | 2020 | 388 | 0.380 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 272 | 0.380 |
Why?
|
| Male | 57 | 2020 | 65830 | 0.380 |
Why?
|
| Diabetic Nephropathies | 5 | 2021 | 114 | 0.380 |
Why?
|
| Myofibroblasts | 4 | 2020 | 78 | 0.380 |
Why?
|
| Cells, Cultured | 13 | 2020 | 3165 | 0.370 |
Why?
|
| Multienzyme Complexes | 4 | 2004 | 88 | 0.370 |
Why?
|
| Cysteine Endopeptidases | 4 | 2004 | 119 | 0.360 |
Why?
|
| Amino Acids | 6 | 2016 | 688 | 0.360 |
Why?
|
| Muscle Development | 1 | 2011 | 76 | 0.360 |
Why?
|
| Fibroblasts | 6 | 2020 | 921 | 0.350 |
Why?
|
| Tripartite Motif Proteins | 4 | 2020 | 18 | 0.340 |
Why?
|
| Muscle Cells | 2 | 2010 | 27 | 0.340 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 119 | 0.340 |
Why?
|
| Acid-Base Equilibrium | 3 | 2009 | 61 | 0.340 |
Why?
|
| Chemokine CXCL6 | 1 | 2009 | 16 | 0.330 |
Why?
|
| Inflammation | 9 | 2022 | 1595 | 0.330 |
Why?
|
| Macrophages | 4 | 2020 | 701 | 0.330 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 100 | 0.330 |
Why?
|
| Actins | 8 | 2017 | 352 | 0.320 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 66 | 0.320 |
Why?
|
| Energy Metabolism | 6 | 2019 | 809 | 0.320 |
Why?
|
| Stem Cells | 2 | 2016 | 752 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2013 | 1406 | 0.310 |
Why?
|
| Living Donors | 2 | 2020 | 118 | 0.310 |
Why?
|
| Gene Expression | 5 | 2020 | 1614 | 0.300 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2022 | 94 | 0.300 |
Why?
|
| Serum Amyloid A Protein | 1 | 2009 | 44 | 0.300 |
Why?
|
| Body Weight | 4 | 2020 | 1034 | 0.300 |
Why?
|
| NF-kappa B | 3 | 2020 | 482 | 0.300 |
Why?
|
| Creatinine | 4 | 2023 | 423 | 0.300 |
Why?
|
| Dietary Fats | 1 | 2010 | 301 | 0.290 |
Why?
|
| Nutritional Requirements | 1 | 2009 | 181 | 0.290 |
Why?
|
| Exercise Therapy | 1 | 2009 | 180 | 0.280 |
Why?
|
| Obesity | 1 | 2019 | 2409 | 0.270 |
Why?
|
| Nephrectomy | 3 | 2020 | 181 | 0.260 |
Why?
|
| STAT6 Transcription Factor | 2 | 2017 | 38 | 0.260 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2006 | 23 | 0.260 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 59 | 0.240 |
Why?
|
| Societies, Medical | 3 | 2005 | 758 | 0.240 |
Why?
|
| Middle Aged | 25 | 2020 | 29350 | 0.240 |
Why?
|
| Anorexia | 1 | 2005 | 24 | 0.240 |
Why?
|
| Thirst | 1 | 2004 | 5 | 0.230 |
Why?
|
| Diabetes Insipidus | 1 | 2004 | 17 | 0.230 |
Why?
|
| RNA, Messenger | 8 | 2020 | 2900 | 0.230 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 139 | 0.230 |
Why?
|
| Photolysis | 1 | 2024 | 12 | 0.230 |
Why?
|
| Cytokines | 5 | 2020 | 1396 | 0.230 |
Why?
|
| rho-Associated Kinases | 2 | 2015 | 56 | 0.230 |
Why?
|
| Receptors, Notch | 2 | 2019 | 214 | 0.230 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3738 | 0.230 |
Why?
|
| Dietary Supplements | 4 | 2016 | 498 | 0.220 |
Why?
|
| Hypernatremia | 1 | 2004 | 33 | 0.220 |
Why?
|
| Goals | 1 | 2005 | 134 | 0.220 |
Why?
|
| Adult | 20 | 2020 | 31928 | 0.220 |
Why?
|
| Hypothalamus | 1 | 2005 | 219 | 0.210 |
Why?
|
| Enzyme Activation | 4 | 2006 | 643 | 0.210 |
Why?
|
| Female | 31 | 2020 | 71587 | 0.210 |
Why?
|
| Water | 2 | 2014 | 198 | 0.210 |
Why?
|
| Myofibrils | 3 | 2010 | 27 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 177 | 0.210 |
Why?
|
| RNA Interference | 3 | 2015 | 542 | 0.210 |
Why?
|
| Metabolism | 2 | 2013 | 44 | 0.200 |
Why?
|
| Halogens | 1 | 2022 | 3 | 0.200 |
Why?
|
| Nutritional Status | 5 | 2013 | 328 | 0.200 |
Why?
|
| Alkenes | 1 | 2022 | 8 | 0.200 |
Why?
|
| Adipose Tissue | 2 | 2016 | 498 | 0.200 |
Why?
|
| Cell Communication | 2 | 2020 | 186 | 0.200 |
Why?
|
| Serum Albumin | 6 | 2008 | 118 | 0.200 |
Why?
|
| Electrodes | 1 | 2022 | 97 | 0.200 |
Why?
|
| Endopeptidases | 1 | 2003 | 118 | 0.200 |
Why?
|
| Neoplasms | 3 | 2016 | 3023 | 0.200 |
Why?
|
| Body Mass Index | 3 | 2020 | 1708 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2020 | 707 | 0.190 |
Why?
|
| Adenosine Triphosphate | 6 | 2017 | 295 | 0.190 |
Why?
|
| Dimethylnitrosamine | 1 | 2020 | 3 | 0.180 |
Why?
|
| Osmosis | 1 | 2020 | 17 | 0.180 |
Why?
|
| Ureteral Obstruction | 4 | 2017 | 109 | 0.180 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2020 | 6 | 0.180 |
Why?
|
| Re-Epithelialization | 1 | 2020 | 12 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 32 | 0.170 |
Why?
|
| Nitrogen | 3 | 2014 | 148 | 0.170 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 231 | 0.170 |
Why?
|
| DNA, Ribosomal | 1 | 2020 | 57 | 0.170 |
Why?
|
| Jagged-1 Protein | 1 | 2020 | 55 | 0.170 |
Why?
|
| Hypoalbuminemia | 2 | 2011 | 16 | 0.170 |
Why?
|
| Fibronectins | 2 | 2017 | 112 | 0.170 |
Why?
|
| Hand Strength | 1 | 2020 | 61 | 0.170 |
Why?
|
| Arteriovenous Fistula | 1 | 2020 | 55 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2014 | 490 | 0.160 |
Why?
|
| Energy Intake | 1 | 2002 | 519 | 0.160 |
Why?
|
| Human Growth Hormone | 2 | 2011 | 78 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2019 | 58 | 0.160 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 230 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2020 | 2026 | 0.150 |
Why?
|
| Apoptosis | 2 | 2015 | 1931 | 0.150 |
Why?
|
| Acute-Phase Reaction | 3 | 2004 | 14 | 0.150 |
Why?
|
| Urea | 2 | 2014 | 239 | 0.150 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 98 | 0.150 |
Why?
|
| Tetracycline | 1 | 2018 | 80 | 0.150 |
Why?
|
| Consensus | 2 | 2013 | 736 | 0.150 |
Why?
|
| Potassium | 2 | 2019 | 289 | 0.150 |
Why?
|
| Transfection | 4 | 2015 | 1088 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 225 | 0.150 |
Why?
|
| Histamine H2 Antagonists | 1 | 2018 | 50 | 0.150 |
Why?
|
| S100 Proteins | 2 | 2015 | 47 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 313 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2020 | 538 | 0.140 |
Why?
|
| Up-Regulation | 3 | 2014 | 905 | 0.140 |
Why?
|
| Patient Care | 1 | 1998 | 104 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 279 | 0.140 |
Why?
|
| Time Factors | 5 | 2019 | 6584 | 0.140 |
Why?
|
| Hip Fractures | 1 | 2018 | 73 | 0.140 |
Why?
|
| Cystatin C | 1 | 2018 | 65 | 0.140 |
Why?
|
| Uncoupling Protein 1 | 1 | 2017 | 28 | 0.140 |
Why?
|
| Ubiquitins | 1 | 2017 | 44 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2539 | 0.140 |
Why?
|
| Aged | 18 | 2020 | 21701 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 528 | 0.140 |
Why?
|
| Nitrites | 2 | 2014 | 51 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 801 | 0.130 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2002 | 95 | 0.130 |
Why?
|
| Kidney Tubules | 2 | 2017 | 78 | 0.130 |
Why?
|
| Trichloroacetic Acid | 1 | 2016 | 5 | 0.130 |
Why?
|
| Trihalomethanes | 1 | 2016 | 5 | 0.130 |
Why?
|
| Histones | 1 | 2020 | 569 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 124 | 0.130 |
Why?
|
| Disease Progression | 3 | 2019 | 2240 | 0.130 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 17 | 0.130 |
Why?
|
| Biomarkers | 9 | 2019 | 3423 | 0.130 |
Why?
|
| Proteinuria | 3 | 2012 | 113 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 684 | 0.130 |
Why?
|
| S100 Calcium-Binding Protein A4 | 4 | 2019 | 22 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1764 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 545 | 0.120 |
Why?
|
| Potassium Radioisotopes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 896 | 0.120 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 273 | 0.120 |
Why?
|
| Cell Movement | 2 | 2020 | 917 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 1414 | 0.120 |
Why?
|
| Janus Kinase 3 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 285 | 0.120 |
Why?
|
| Hypertension | 2 | 2020 | 1391 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1326 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 494 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 774 | 0.120 |
Why?
|
| Bromides | 1 | 2014 | 4 | 0.120 |
Why?
|
| Bromine | 1 | 2014 | 5 | 0.120 |
Why?
|
| Financing, Organized | 1 | 2014 | 21 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2006 | 1305 | 0.120 |
Why?
|
| Iodides | 1 | 2014 | 14 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2015 | 93 | 0.120 |
Why?
|
| Organic Chemicals | 1 | 2014 | 60 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 226 | 0.110 |
Why?
|
| Actomyosin | 2 | 2005 | 8 | 0.110 |
Why?
|
| Water Supply | 1 | 2014 | 27 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 79 | 0.110 |
Why?
|
| Renal Elimination | 1 | 2014 | 10 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 182 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2019 | 12994 | 0.110 |
Why?
|
| Nitrogen Dioxide | 1 | 2014 | 18 | 0.110 |
Why?
|
| Solvents | 1 | 2014 | 46 | 0.110 |
Why?
|
| Ammonia | 1 | 2014 | 77 | 0.110 |
Why?
|
| Uncertainty | 1 | 2014 | 105 | 0.110 |
Why?
|
| Morpholines | 1 | 2014 | 64 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 713 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 262 | 0.110 |
Why?
|
| Bicarbonates | 3 | 2019 | 100 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2016 | 307 | 0.110 |
Why?
|
| Amino Acids, Essential | 1 | 2013 | 28 | 0.110 |
Why?
|
| Pyrroles | 1 | 2015 | 187 | 0.110 |
Why?
|
| 3T3-L1 Cells | 2 | 2019 | 55 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2020 | 6660 | 0.100 |
Why?
|
| Activins | 1 | 2013 | 74 | 0.100 |
Why?
|
| Research Personnel | 1 | 2014 | 136 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2014 | 56 | 0.100 |
Why?
|
| Piperidines | 1 | 2015 | 238 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2017 | 830 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 61 | 0.100 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 472 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2016 | 479 | 0.100 |
Why?
|
| Decarboxylation | 1 | 2012 | 3 | 0.100 |
Why?
|
| Chlorophyta | 1 | 2012 | 4 | 0.100 |
Why?
|
| Chloramines | 1 | 2012 | 5 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 1440 | 0.100 |
Why?
|
| Asparagine | 1 | 2012 | 22 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 686 | 0.100 |
Why?
|
| Tyrosine | 1 | 2013 | 158 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 879 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2006 | 1757 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 278 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 84 | 0.100 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2019 | 14 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2015 | 417 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 2 | 2020 | 146 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2012 | 163 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2013 | 397 | 0.090 |
Why?
|
| YY1 Transcription Factor | 1 | 2011 | 16 | 0.090 |
Why?
|
| Interleukin-1beta | 2 | 2023 | 168 | 0.090 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2011 | 56 | 0.090 |
Why?
|
| Argininosuccinate Lyase | 1 | 2011 | 65 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1632 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 321 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2006 | 834 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 395 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2011 | 125 | 0.090 |
Why?
|
| Oxygen | 1 | 2014 | 580 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 933 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 610 | 0.080 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2010 | 5 | 0.080 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2010 | 1 | 0.080 |
Why?
|
| Myogenin | 1 | 2010 | 10 | 0.080 |
Why?
|
| RNA, Ribosomal | 1 | 2010 | 62 | 0.080 |
Why?
|
| Chemokine CXCL16 | 1 | 2009 | 10 | 0.080 |
Why?
|
| MyoD Protein | 1 | 2010 | 26 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2010 | 139 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1070 | 0.080 |
Why?
|
| Physical Endurance | 1 | 2009 | 51 | 0.080 |
Why?
|
| Chemokines | 1 | 2009 | 138 | 0.080 |
Why?
|
| Receptors, Angiotensin | 1 | 2009 | 21 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 25 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 260 | 0.080 |
Why?
|
| Risk Factors | 6 | 2011 | 11071 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2009 | 128 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 292 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2011 | 609 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2010 | 809 | 0.080 |
Why?
|
| Myositis | 1 | 2010 | 104 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2014 | 556 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 2529 | 0.070 |
Why?
|
| Cell Division | 1 | 2010 | 774 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2017 | 161 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2013 | 527 | 0.070 |
Why?
|
| Anthropometry | 2 | 2009 | 202 | 0.070 |
Why?
|
| Swimming Pools | 2 | 2019 | 12 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 177 | 0.070 |
Why?
|
| Spain | 2 | 2019 | 65 | 0.070 |
Why?
|
| Carotid Artery, Common | 2 | 2020 | 69 | 0.070 |
Why?
|
| Ghrelin | 1 | 2007 | 53 | 0.070 |
Why?
|
| Losartan | 2 | 2004 | 37 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 370 | 0.070 |
Why?
|
| Myoblasts | 1 | 2007 | 36 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1912 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2004 | 57 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2006 | 1489 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3748 | 0.070 |
Why?
|
| Albuminuria | 2 | 2004 | 113 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 3 | 2015 | 407 | 0.070 |
Why?
|
| Models, Biological | 3 | 2014 | 1535 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 787 | 0.070 |
Why?
|
| Protein Modification, Translational | 1 | 2006 | 2 | 0.070 |
Why?
|
| Vascular Patency | 2 | 2019 | 196 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1304 | 0.060 |
Why?
|
| Sp1 Transcription Factor | 2 | 2006 | 45 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 65 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3970 | 0.060 |
Why?
|
| Adiponectin | 1 | 2006 | 127 | 0.060 |
Why?
|
| Plasmids | 2 | 2004 | 527 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 85 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 312 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 400 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 139 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3843 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2785 | 0.060 |
Why?
|
| Eating | 2 | 2007 | 387 | 0.060 |
Why?
|
| Cytochromes c | 1 | 2004 | 52 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 158 | 0.060 |
Why?
|
| Monocytes | 2 | 2017 | 361 | 0.050 |
Why?
|
| Kinetics | 4 | 2017 | 1354 | 0.050 |
Why?
|
| Affect | 1 | 2004 | 173 | 0.050 |
Why?
|
| Double-Blind Method | 4 | 2011 | 1669 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 184 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2017 | 621 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 336 | 0.050 |
Why?
|
| Young Adult | 5 | 2019 | 9902 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2005 | 454 | 0.050 |
Why?
|
| Albumins | 1 | 2003 | 98 | 0.050 |
Why?
|
| Infusions, Parenteral | 1 | 2002 | 100 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3228 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 124 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2017 | 2703 | 0.050 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2002 | 21 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 479 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2004 | 873 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2003 | 164 | 0.050 |
Why?
|
| Protein Deficiency | 1 | 2002 | 20 | 0.050 |
Why?
|
| Nephrologists | 1 | 2021 | 14 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 93 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2020 | 717 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2006 | 1195 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2023 | 164 | 0.050 |
Why?
|
| Diet | 1 | 2009 | 1196 | 0.050 |
Why?
|
| Models, Animal | 2 | 2015 | 483 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 109 | 0.040 |
Why?
|
| Acute-Phase Proteins | 1 | 2001 | 50 | 0.040 |
Why?
|
| Patient Selection | 2 | 2016 | 732 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 335 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2020 | 29 | 0.040 |
Why?
|
| United States | 4 | 2013 | 11663 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5503 | 0.040 |
Why?
|
| Ribonucleases | 3 | 2002 | 51 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 246 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 7194 | 0.040 |
Why?
|
| Adipocytes, White | 1 | 2019 | 26 | 0.040 |
Why?
|
| Cadherins | 1 | 2020 | 186 | 0.040 |
Why?
|
| Leptin | 1 | 2001 | 225 | 0.040 |
Why?
|
| Lewis Bases | 1 | 2018 | 1 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 399 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adsorption | 1 | 2018 | 37 | 0.040 |
Why?
|
| Silicates | 1 | 2018 | 11 | 0.040 |
Why?
|
| Sunlight | 1 | 2018 | 27 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1971 | 0.040 |
Why?
|
| Tetracyclines | 1 | 2018 | 22 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 170 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 109 | 0.040 |
Why?
|
| Feces | 1 | 2002 | 787 | 0.040 |
Why?
|
| Catalysis | 1 | 2018 | 137 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2006 | 999 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1487 | 0.040 |
Why?
|
| Sepsis | 1 | 2003 | 516 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 2017 | 56 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 17457 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cofilin 1 | 1 | 2017 | 14 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 1136 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 106 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 132 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 673 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 1998 | 131 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 318 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2017 | 191 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 2082 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2016 | 59 | 0.030 |
Why?
|
| Swimming | 1 | 2016 | 28 | 0.030 |
Why?
|
| Quality of Life | 2 | 2021 | 2131 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 777 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 249 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 830 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2015 | 37 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1735 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2015 | 18 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 400 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 73 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2015 | 147 | 0.030 |
Why?
|
| Foundations | 1 | 2014 | 22 | 0.030 |
Why?
|
| Folic Acid | 1 | 2017 | 298 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 101 | 0.030 |
Why?
|
| Jugular Veins | 1 | 2015 | 78 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 137 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 130 | 0.030 |
Why?
|
| Kidney Concentrating Ability | 1 | 2014 | 16 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1079 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 812 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 8 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2014 | 13 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2014 | 83 | 0.030 |
Why?
|
| Renin-Angiotensin System | 2 | 2005 | 103 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 3690 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 456 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1384 | 0.030 |
Why?
|
| Orosomucoid | 2 | 2004 | 9 | 0.030 |
Why?
|
| Ceruloplasmin | 2 | 2004 | 15 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 185 | 0.030 |
Why?
|
| Plasma Volume | 2 | 2003 | 15 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2013 | 41 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 6292 | 0.030 |
Why?
|
| Dexamethasone | 2 | 2006 | 284 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 27 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 25 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 378 | 0.020 |
Why?
|
| Aldehydes | 1 | 2012 | 31 | 0.020 |
Why?
|
| Adipokines | 1 | 2013 | 72 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 201 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 99 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2013 | 102 | 0.020 |
Why?
|
| Enterobacter | 1 | 1972 | 15 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1971 | 22 | 0.020 |
Why?
|
| Argininosuccinate Synthase | 1 | 2011 | 25 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 139 | 0.020 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 201 | 0.020 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2011 | 24 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3683 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1814 | 0.020 |
Why?
|
| Mitochondria, Muscle | 1 | 2011 | 38 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2012 | 188 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 2011 | 36 | 0.020 |
Why?
|
| Protein Phosphatase 2C | 1 | 2011 | 60 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 313 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5175 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 95 | 0.020 |
Why?
|
| Research Design | 2 | 2008 | 755 | 0.020 |
Why?
|
| Life Style | 1 | 2013 | 454 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 395 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 537 | 0.020 |
Why?
|
| Arginine | 1 | 2011 | 349 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2006 | 2301 | 0.020 |
Why?
|
| Autophagy | 1 | 2012 | 420 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1124 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 85 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 134 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 159 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 1998 | 3985 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 783 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 88 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1216 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2007 | 66 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2007 | 28 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1612 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2007 | 150 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 205 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2007 | 115 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 614 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 869 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2006 | 129 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2007 | 236 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 2655 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1330 | 0.020 |
Why?
|
| Hong Kong | 1 | 2005 | 16 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1834 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 254 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 21 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 1165 | 0.010 |
Why?
|
| Life Tables | 1 | 2004 | 28 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2004 | 55 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 1187 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3064 | 0.010 |
Why?
|
| Metallothionein | 1 | 2004 | 14 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 179 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 449 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2157 | 0.010 |
Why?
|
| Desoxycorticosterone | 1 | 2003 | 15 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 343 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 93 | 0.010 |
Why?
|
| Superoxides | 1 | 2003 | 130 | 0.010 |
Why?
|
| NADPH Oxidases | 1 | 2003 | 114 | 0.010 |
Why?
|
| Plicamycin | 1 | 2002 | 4 | 0.010 |
Why?
|
| Butadienes | 1 | 2002 | 21 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 456 | 0.010 |
Why?
|
| Vasodilation | 1 | 2003 | 179 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2003 | 203 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 330 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1972 | 96 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 45 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3171 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3057 | 0.010 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2002 | 82 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1972 | 388 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 403 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2003 | 323 | 0.010 |
Why?
|
| Nitriles | 1 | 2002 | 155 | 0.010 |
Why?
|
| Transferrin | 1 | 2001 | 50 | 0.010 |
Why?
|
| Heart Failure | 2 | 2005 | 2399 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 615 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 744 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 723 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 522 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 525 | 0.010 |
Why?
|
| Adolescent | 2 | 2009 | 20542 | 0.010 |
Why?
|
| Health Priorities | 1 | 1999 | 39 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 687 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 832 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 141 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 1369 | 0.010 |
Why?
|
| Congresses as Topic | 1 | 1999 | 187 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1834 | 0.010 |
Why?
|
| Research | 1 | 1999 | 272 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 1096 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1676 | 0.010 |
Why?
|
| Hospitalization | 1 | 2004 | 1883 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 2657 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1999 | 1200 | 0.010 |
Why?
|
| Cytosine Nucleotides | 1 | 1972 | 2 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1972 | 12 | 0.010 |
Why?
|
| Uracil Nucleotides | 1 | 1972 | 17 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1972 | 15 | 0.010 |
Why?
|
| Polynucleotides | 1 | 1972 | 9 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1972 | 15 | 0.010 |
Why?
|
| Chymotrypsinogen | 1 | 1971 | 1 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 97 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1972 | 67 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1972 | 41 | 0.010 |
Why?
|
| Yeasts | 1 | 1972 | 43 | 0.010 |
Why?
|
| Dextrans | 1 | 1971 | 47 | 0.010 |
Why?
|
| Gels | 1 | 1971 | 73 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1972 | 469 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1972 | 612 | 0.010 |
Why?
|
| RNA | 1 | 1972 | 601 | 0.000 |
Why?
|
| Bacteria | 1 | 1971 | 537 | 0.000 |
Why?
|